Гуам
High income
- Общ преглед
- РазпроÑтранение на затлъÑÑ‚Ñването
- Разбивки на наÑелението
- Причини
- СъпътÑтващи заболÑваниÑ
- Политики
- Contextual factors
Report cards
Our report cards collate all the most-recent graphics for this country. If you would like to produce a custom report based on selected graphics, just tap the Add to custom PDF button below the graphics you would like to use.
Разбивки на наÑелението
Причини
КонÑÑƒÐ¼Ð°Ñ†Ð¸Ñ Ð½Ð° плодове
КонÑÑƒÐ¼Ð°Ñ†Ð¸Ñ Ð½Ð° преработено меÑо
КонÑÑƒÐ¼Ð°Ñ†Ð¸Ñ Ð½Ð° зърнени култури
ДепреÑиÑ
ТревожноÑÑ‚
Причини за затлъÑÑ‚Ñването »
Like all chronic diseases, the root causes/drivers of obesity are complex. Select here to view 'other' root causes/drivers.ИзтеглÑне на карта за отчитане
СъпътÑтващи заболÑваниÑ
Рак на хранопровода
Рак на гърдата
Колоректален рак
Рак на панкреаÑа
Рак на Ð¶Ð»ÑŠÑ‡Ð½Ð¸Ñ Ð¼ÐµÑ…ÑƒÑ€
Рак на бъбреците
Рак на матката
Преобладаване на диабета
Ovarian Cancer
Leukemia
Liver & bile duct cancer
Mulitple Myeloma
Non Hodgkin Lymphoma
Thyroid Cancer
ИзтеглÑне на карта за отчитане
Политики
Contextual factors
РазпроÑтранение на затлъÑÑ‚Ñването
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| КоличеÑтво на пробите: | 1454 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| Забележки: | Crude prevalence |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Деца, 2013-2014
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 4-19 |
| КоличеÑтво на пробите: | 30579 |
| Обхваната зона: | Ðационално |
| Референции: | Paulino YC, Guerrero RT, Uncangco AA, Rosadino MG, Quinene JC, Natividad ZN. Overweight and Obesity Prevalence among Public School Children in Guam. J Health Care Poor Underserved. 2015;26(2 Suppl):53-62. doi:10.1353/hpu.2015.0066 |
| Cutoffs: | CDC |
Ðаднормено тегло/затлъÑÑ‚Ñване по образование
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| КоличеÑтво на пробите: | 1454 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| Забележки: | Crude prevalence. |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Ðаднормено тегло/затлъÑÑ‚Ñване по възраÑÑ‚
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| КоличеÑтво на пробите: | 1454 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Ðаднормено тегло/затлъÑÑ‚Ñване по етничеÑка принадлежноÑÑ‚
Ethnic groups are as defined by publication of origin and are not as defined by WOF. In some instances ethnicity is conflated with nationality and/or race.
ВъзраÑтни, 2023
| Тип анкета: | Самоотчитане |
| ВъзраÑÑ‚: | 18+ |
| КоличеÑтво на пробите: | 1454 |
| Обхваната зона: | Ðационално |
| Референции: | Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data [online]. 2025. [accessed Mon, 17 Nov 2025 13:34:31 GMT]. URL: https://www.cdc.gov/brfss/brfssprevalence/. |
| Забележки: | Insufficient sample size for other ethnic groups. Crude prevalence. |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Estimated per capita fruit intake
ВъзраÑтни, 2017
| ВъзраÑÑ‚: | 25+ |
| Обхваната зона: | Ðационално |
| Референции: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| ОпределениÑ: | Estimated per capita fruit intake (g/day) |
Estimated per capita processed meat intake
ВъзраÑтни, 2017
| ВъзраÑÑ‚: | 25+ |
| Обхваната зона: | Ðационално |
| Референции: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| ОпределениÑ: | Estimated per capita processed meat intake (g per day) |
Estimated per capita whole grains intake
ВъзраÑтни, 2017
| Тип анкета: | Измерено |
| ВъзраÑÑ‚: | 25+ |
| Референции: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| ОпределениÑ: | Estimated per-capita whole grains intake (g/day) |
ПÑихично здраве – депреÑивни разÑтройÑтва
ВъзраÑтни, 2021
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depression per 100,000 population (adults 20+ years) |
Мъже, 2021
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depression per 100,000 population (adults 20+ years) |
Жени, 2021
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depression per 100,000 population (adults 20+ years) |
Деца, 2021
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Момчета, 2021
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
Момичета, 2021
| Обхваната зона: | Ðационално |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
| ОпределениÑ: | Number living with depressive disorder per 100,000 population (Under 20 years of age) |
ПÑихично здраве – тревожни разÑтройÑтва
ВъзраÑтни, 2021
| ВъзраÑÑ‚: | 20+ |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| ОпределениÑ: | Number living with anxiety per 100,000 population |
Мъже, 2021
| ВъзраÑÑ‚: | 20+ |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| ОпределениÑ: | Number living with anxiety per 100,000 population |
Жени, 2021
| ВъзраÑÑ‚: | 20+ |
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25). |
| ОпределениÑ: | Number living with anxiety per 100,000 population |
Деца, 2021
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Момчета, 2021
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Момичета, 2021
| Референции: | Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25) |
Рак на хранопровода
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на гърдата
Жени, 2022
| ВъзраÑÑ‚: | 20 |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Колоректален рак
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на панкреаÑа
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на Ð¶Ð»ÑŠÑ‡Ð½Ð¸Ñ Ð¼ÐµÑ…ÑƒÑ€
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на бъбреците
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Мъже, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Рак на матката
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2020
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161 |
| ОпределениÑ: | Age-standardized indicence rates per 100 000 |
Преобладаване на диабета
ВъзраÑтни, 2024
| Референции: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org |
ВъзраÑтни, 2021
| ВъзраÑÑ‚: | 20-79 |
| Обхваната зона: | Ðационално |
| Референции: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org |
| ОпределениÑ: | Age-adjusted comparative prevalence of diabetes, % |
ВъзраÑтни, 2019
| ВъзраÑÑ‚: | 20-79 |
| Референции: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org |
| ОпределениÑ: | Diabetes age-adjusted comparative prevalence (%). |
ВъзраÑтни, 2017
| Референции: | Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org |
| ОпределениÑ: | Diabetes age-adjusted comparative prevalence (%). |
Ovarian Cancer
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Leukemia
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Liver and intrahepatic bile duct Cancer
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Multiple Myeloma
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Indicence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Non Hodgkin Lymphoma
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
| ОÑвен ако не е поÑочено друго, наднорменото тегло Ñе отнаÑÑ Ð´Ð¾ ИТМ между 25 kg и 29,9°kg/m², затлъÑÑ‚Ñването Ñе отнаÑÑ Ð´Ð¾ ИТМ, по-голÑм от 30°. | |
Thyroid Cancer
Мъже, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Жени, 2022
| ВъзраÑÑ‚: | 20+ |
| Обхваната зона: | Ðационално |
| Референции: | Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24] |
| ОпределениÑ: | Incidence per 100,000 |
Policies, Interventions and Actions
Contextual factors
Disclaimer: These contextual factors should be interpreted with care. Results are updated as regularly as possible and use very specific criteria. The criteria used and full definitions are available for download at the bottom of this page.
Tap on a tick to find out more about policies influencing this factor.
Labelling
| Is there mandatory nutrition labelling? | Absent |
| Front-of-package labelling? | Absent |
| Back-of-pack nutrition declaration? | Absent |
| Color coding? | Absent |
| Warning label? | Absent |
Regulation and marketing
| Are there fiscal policies on unhealthy products? | Absent |
| Tax on unhealthy foods? | Absent |
| Tax on unhealthy drinks? | Absent |
| Are there fiscal policies on healthy products? | Absent |
| Subsidy on fruits? | Absent |
| Subsidy on vegetables? | Absent |
| Subsidy on other healthy products? | Absent |
| Mandatory limit or ban of trans fat (all settings)? | Absent |
| Mandatory limit of trans fats in place (all settings)? | Absent |
| Ban on trans-fats or phos in place (all settings)? | Absent |
| Are there any mandatory policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
| Mandatory restriction on broadcast media? | Absent |
| Mandatory restriction on non-broadcast media? | Absent |
| Voluntary policies/marketing restrictions on the promotion of unhealthy food/drinks to children? | Absent |
| Are there mandatory standards for food in schools? | Absent |
| Are there any mandatory nutrient limits in any manufactured food products? | Absent |
| Nutrition standards for public sector procurement? | Absent |
Political will and support
| National obesity strategy or nutrition and physical activity national strategy? | Present |
| National obesity strategy? | Present |
| National childhood obesity strategy? | Absent |
| Comprehensive nutrition strategy? | Present |
| Comprehensive physical activity strategy? | Present |
| Evidence-based dietary guidelines and/or RDAs? | Absent |
| National target(s) on reducing obesity? | Present |
| Promotion of breastfeeding? | Present |
Monitoring and surveillance
| Monitoring of the prevalence and incidence for the main obesity-related NCDs and risk factors? | Absent |
| Within 5 years? | Absent |
Governance and resource
| Multi-sectoral national co-ordination mechanism for obesity or nutrition (including obesity)? | Absent |
Key
Last updated September 13, 2022
Download contextual factors as a PDF Contextual factors definitions